The estimated Net Worth of Micah W Young is at least $4.26 Million dollars as of 12 November 2021. Mr. Young owns over 3,700 units of Masimo Corp stock worth over $1,243,872 and over the last 7 years he sold MASI stock worth over $1,102,600. In addition, he makes $1,913,280 as Chief Financial Officer und Executive Vice President at Masimo Corp.
Sign up
Mr. Young MASI stock SEC Form 4 insiders trading
Micah has made over 6 trades of the Masimo Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 3,700 units of MASI stock worth $1,102,600 on 12 November 2021.
The largest trade he's ever made was exercising 12,087 units of Masimo Corp stock on 16 September 2019 worth over $1,031,142. On average, Micah trades about 2,588 units every 49 days since 2017. As of 12 November 2021 he still owns at least 10,893 units of Masimo Corp stock.
You can see the complete history of Mr. Young stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Micah Young biography
Micah W. Young serves as Chief Financial Officer, Executive Vice President of the Company. From July 2012 to September 2017, Mr. Young served as Vice President, Finance, at NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. Prior to that time, he served as NuVasive, Inc.’s Senior Director, Finance, Global Operations, from December 2009 to July 2012. From 2002 to 2009, Mr. Young held various accounting and finance positions with Zimmer Holdings, Inc., a company focused on the design, development, manufacture and marketing of orthopedic reconstructive, spinal and trauma devices, dental implants and related surgical products. Prior to his time at Zimmer Holdings, Inc., Mr. Young was an accountant at Deloitte & Touche LLP from 2000 to 2002. He holds a Bachelor of Science, Accounting and Criminal Justice from Indiana Wesleyan University and is a Certified Public Accountant (inactive).
What is the salary of Micah Young?
As the Chief Financial Officer und Executive Vice President of Masimo Corp, the total compensation of Micah Young at Masimo Corp is $1,913,280. There are 6 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.
How old is Micah Young?
Micah Young is 41, he's been the Chief Financial Officer und Executive Vice President of Masimo Corp since 2017. There are 22 older and 2 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.
What's Micah Young's mailing address?
Micah's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.
Insiders trading at Masimo Corp
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill und Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
What does Masimo Corp do?
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
What does Masimo Corp's logo look like?
Complete history of Mr. Young stock trades at Masimo Corp
Masimo Corp executives and stock owners
Masimo Corp executives and other stock owners filed with the SEC include:
-
Joseph Kiani,
Chairman of the Board, Chief Executive Officer -
Bilal Muhsin,
Chief Operating Officer -
Joseph E. Kiani,
Founder, CEO & Chairman -
Tao Levy,
Executive Vice President - Business Development -
Anand Sampath,
Executive Vice President - Operations & Clinical Research -
Tom McClenahan,
Executive Vice President, General Counsel, Corporate Secretary -
Micah Young,
Chief Financial Officer, Executive Vice President -
Jon Coleman,
President - Worldwide Sales, Professional Services and Medical Affairs -
Yongsam Lee,
Executive Vice President, Chief Information Officer -
Bilal Muhsin,
Chief Operating Officer -
Micah Young,
Exec. VP of Fin. & CFO -
Thomas Samuel McClenahan,
Exec. VP, Gen. Counsel & Corp. Sec. -
Tao Leopold Levy,
Exec. VP of Bus. Devel. -
Adam Mikkelson,
Independent Director -
Craig Reynolds,
Independent Director -
Thomas Harkin,
Independent Director -
Sanford Fitch,
Independent Director -
H Michael Cohen,
Independent Director -
Julie Shimer,
Independent Director -
Steven Barker,
Director -
Dr. Steven J. Barker,
Chairman of Scientific Advisory Board & Chief Science Officer -
Eli Kammerman,
Investor Relations Officer -
J. Todd Koning,
Chief Accounting Officer -
Jon Coleman,
Pres of Worldwide Sales, Professional Services & Medical Affairs -
Yongsam Lee,
Exec. VP & Chief Information Officer -
Thierry Leclercq,
Exec. VP of Bus. Devel. -
Anand Sampath,
Exec. VP of Operations & Clinical Research -
Joe E Kiani,
CEO and Chairman of the Board -
Raad Mark De,
EVP & Chief Financial Officer -
Thierry Leclercq,
EVP, Bus Dev -
Paul Jansen,
Executive VP, Marketing -
Thomas Samuel Mc Clenahan,
EVP, GEN COUNSEL & CORP SEC -
Michelle Brennan,
Director -
Blair Tripodi,
COO, Consumer Division -
Christopher Kilpatrick,
EVP, Business Dev., GC & Sec. -
Olivier Berthon,
President, Masimo Europe -
Michael O'reilly,
EVP, Medical Affairs -
Ammar Al Ali,
Chief Technical Officer -
David Goodman,
EVP, Business Development -
Stephen M Moran,
EVP, General Counsel -
Stephen E. Paul,
Vice President, US Acute Care -
Rick Fishel,
President of Masimo Americas -
Robert Coleman,
Director -
Brian Campbell,
-
Mohamed Elmandjra,
Pres., Worldwide OEM Business -
Edward L Cahill,
Director -
Jack W Lasersohn,
Director -
Anthony Allan,
Chief Operating Officer -
Robert A Chapek,
Director -
Ramshorst David J Van,
SVP, Chief Accounting Officer -
Kevin P Duffy,
President, Consumer -
Capital Management Lp Polit...,
-
Rolf A Classon,
Director